维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Konopski"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial显示文摘	John Willy Haukeland Zbigniew Konopski Heidi Beate Eggesb? Hilde L?land von Volkmann Gabriele Raschpichler Kristian Bj?ro Terese Haaland Else Marit L?berg K?re Birkeland	2009	Scandinavian Journal of Gastroenterology2009，，7：	3
2	Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver显示文摘	Hans Lannerstedt Zbigniew Konopski Leiv Sandvik Terese Haaland Else Marit Lø berg John Willy Haukeland	2013	Scandinavian Journal of Gastroenterology2013，，1：	2
3	Abnor-mal glucose tolerance is a predictor of steatohepatitis andfibrosis in patients with non-alcoholic fatty liver disease显示文摘	Haukeland JW Konopski Z Linnestad P	2005	Scand J Gastroenterol2005，40，12：	1
4	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，：	1
5	Abnormal glucose tolerance is a predic- tor of steatohepatitis and fibrosis in patients with non-acobolie fatty liver disease 显示文摘	Haukeland JW Konopski Z	2005	Scand J Gastroenterol2005，40，：	1
6	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCI2 显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，6：	1
7	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCI2显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，6：	1
8	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2显示文摘	Haukeland JW Dams JK Konopski Z	2006	J Hepatol2006，44，6：	1
9	Metformin in pa- tients with non-alcoholic fatty liver disease: a randomized,con- trolled trial显示文摘	Haukeland JW Konopski Z Eggesbo HB	2009	Scand J Gastroenterol2009，44，7：	1
10	Metforminin patients with non-alcoholic fatty liver disease : arandomized,controlled trial 显示文摘	Haukeland JW Konopski Z Eggesb0 HB	2009	Scand J Gastroenterol2009，44，7：	1
11	Metformin in patients with non-alcoholic fatty liver disease: a randomized controlled trial 显示文摘	Haukeland JW Konopski Z Eggesb HB	2009	Scand J Gastroenterol2009，44，7：	1
12	Systemic intlammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 显示文摘	Haukelandl JW Dama JK Konopski Z	2006	J Hepatol2006，44，：	1
13	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 显示文摘	Haukeland JW Konopski Z Haaland T	2006	J Hepatol2006，44，6：	1
14	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，6：	1
15	Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial显示文摘	Haukeland JW Konopski Z Eggesbo HB	2009	Scandinavian Journal of Gastroenterology2009，44，：	1
16	Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial显示文摘	Haukeland lW Konopski Z Eggesbo RB	2009	Scand 1 Gastroenterol2009，44，7：	1
17	Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial显示文摘	Haukeland JW Konopski Z Eggesbo HB	2009	Scand J Gastroenterol2009，44，：	1
18	Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease 显示文摘	HAUKELAND J W KONOPSKI Z LINNESTAD P	2005	Scand J Gastroenterol2005，40，12：	1
19	A biosensor based on photonic crystal surface wave with an independent显示文摘	V N Konopsky E V Alieva	2010	Biosensors and Bioelectronics2010，25，5：	1
20	Systemic inflamma-tion in non - alcoholic fatty liver disease is characterized by elevated levels of CCI2 显示文摘	Haukeland JW Damas JK Konopski Z	2006	J Hepatol2006，44，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示